Clinical Trial

Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 3, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-13; most recent amendment 2025-05-28.
Status change: Not Yet Recruiting → Recruiting 2025-05-28
Trial Details
NCT Number NCT06690099
Lead Sponsor Devyser Inc.
Conditions Rhesus D Genotype, Pregnancy
Enrollment 500 participants
Start Date 2025-04-07
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-03